NTAGI recommends reducing Covishield dose gap to 8-16 weeks

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...
Medlarge COVID-19 Updates, Featured, Latest
India's covid vaccine

The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap of Covid vaccine Covishield to 8 to 16 weeks after 1st dose of vaccine in view of ongoing Omicron pandemic, said a source on Sunday.

Presently, the second dose of Covishield is being administered 12-16 weeks after the first dose under the national vaccination drive. India’s apex body on immunisation NTAGI has recommended this in view of recent surge in the global Covid caseload.

The recommendation is expected to ramp up the administration of the second dose of Covishield to the remaining population amid rising cases in European nations and some other countries.

The government had on May 13, 2021 extended the gap between the first and second doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks based on the recommendations by NTAGI that provides guidance to the Union Health Ministry on the immunisation.


Comments